Cardiology
Conference Coverage
Bempedoic acid cuts CV events in statin-intolerant patients: CLEAR Outcomes
The CLEAR Outcomes trial establishes this new drug as an important addition to available nonstatin LDL cholesterol–lowering therapies, experts say...
Conference Coverage
Transcatheter tricuspid valve repair effective and safe for regurgitation
In a randomized pivotal trial, a percutaneous repair of tricuspid valve regurgitation was effective and safe.
Feature
Docs struggle to keep up with the flood of new medical knowledge. Here’s advice
The sheer number of new studies may even force some doctors to retreat from areas where they have not kept up, according to a physician professor...
From the Journals
Any level of physical activity tied to better later-life memory
Those who exercised to any extent in adulthood had significantly better cognitive scores later in life, compared with their peers who were...
Conference Coverage
500 more steps a day tied to 14% lower CVD risk in older adults
New study supports the value of modest but consistent activity to improve heart health.
News
FDA declines approval for omecamtiv mecarbil in HFrEF
The Food and Drug Administration’s decision followed the consensus of its advisory committee.
Conference Coverage
Frequent cannabis use tied to coronary artery disease
Daily cannabis use, but not less frequent cannabis use, was associated with CAD.
Conference Coverage
Old drug verapamil may have new use in type 1 diabetes
In randomized trial, the old cardiac agent slowed the destruction of insulin-producing beta cells in youth with new-onset type 1 diabetes.
Conference Coverage
Insomnia, short sleep linked to greater risk for MI
Health care professionals should be asking all patients about their sleep as a key aspect of maintaining heart health, says a sleep expert.
From the Journals
Fewer than 10% of eligible type 2 diabetes patients get new, pricey drugs
Only 9% of eligible adults with T2D received treatment with an SGLT2 inhibitor or GLP-1 agonist in 2017-2020, in a new analysis.
From the Journals
Artificial sweetener in ‘keto foods’ tied to cardiovascular risk
Artificial sweeteners are “generally recognized as safe” by the FDA, so there is no requirement for long-term safety studies, and little is known...